Contents

Search


Prolaris

Indications: - multiple gene analysis* for assessment of prostate cancer * 46-gene expression signature Clinical significance: - includes cell cycle progression genes selected based upon correlation with prostate tumor cell proliferation - low gene expression associated with a low risk of disease progression - high gene expression associated with disease progression

General

molecular diagnostic test

References

  1. Mulcahy N 'Notable Differences' With 3 Prostate Cancer Genomics Tests. Medscape - May 20, 2018. https://www.medscape.com/viewarticle/896937
  2. Prolaris https://prolaris.com/prolaris-for-physicians/what-is-prolaris/